Table 3. Clinical findings of patients with HAdv infection compared with other respiratory virus infections*.
Characteristic | HAdv | Other respiratory virus* | p value |
Cough, n/N (%) | 463/547 (84.6) | 8991/9643 (93.2) | <0.001 |
Rhinorrhea, n/N (%) | 429/531 (80.8) | 8024/9499 (84.5) | 0.023 |
Malaise, n/N (%) | 435/545 (79.8) | 8351/9638 (86.6) | <0.001 |
Sore throat, n/N (%) | 351/542 (64.8) | 7372/9513 (77.5) | <0.001 |
Headache, n/N (%) | 286/542 (52.8) | 6950/9605 (72.4) | <0.001 |
Conjunctival injection, n/N (%) | 269/529 (50.9) | 4421/9363 (47.2) | 0.104 |
Muscle soreness, n/N (%) | 163/537 (30.4) | 4666/9521 (49.0) | <0.001 |
Eye pain, n/N (%) | 100/524 (19.1) | 3200/9393 (34.1) | <0.001 |
Rhonchi, n/N (%) | 67/527 (12.7) | 1013/9340 (10.8) | 0.182 |
Photophobia, n/N (%) | 32/522 (6.1) | 1017/9329 (10.9) | 0.001 |
Dizziness, n/N (%) | 25/524 (4.8) | 1415/9333 (15.2) | <0.001 |
Earache, n/N (%) | 24/525 (4.6) | 917/9340 (9.8) | <0.001 |
Wheezing, n/N (%) | 22/523 (4.2) | 630/9331 (6.8) | 0.023 |
Peru, 2000–2010.
Seasonal influenza A, Influenza A (H1N1) pdm09, HSV, influenza B, parainfluenza, enterovirus, HBoV, hMPV and respiratory syncytial virus. Those with co-infections or with missing responses were removed from the analysis.